{"id":470530,"date":"2023-08-24T18:07:07","date_gmt":"2023-08-25T01:07:07","guid":{"rendered":"https:\/\/nai500.com\/?p=470530"},"modified":"2023-08-24T18:07:07","modified_gmt":"2023-08-25T01:07:07","slug":"%e7%bd%97%e6%b0%8f-%e6%84%8f%e5%a4%96%e6%b3%84%e9%9c%b2-%e6%95%b0%e6%8d%ae-%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1-%e4%b8%8a%e6%b6%a8","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2023\/08\/%e7%bd%97%e6%b0%8f-%e6%84%8f%e5%a4%96%e6%b3%84%e9%9c%b2-%e6%95%b0%e6%8d%ae-%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80%e8%82%a1-%e4%b8%8a%e6%b6%a8\/","title":{"rendered":"\u7f57\u6c0f\u610f\u5916\u6cc4\u9732\u7684\u6570\u636e\uff0c\u523a\u6fc0\u4e00\u6279\u751f\u7269\u79d1\u6280\u80a1\u7eb7\u7eb7\u4e0a\u6da8"},"content":{"rendered":"<p>8\u670823\u65e5\uff0c\u4e00\u6279\u751f\u7269\u5236\u836f\u516c\u53f8\u7684\u80a1\u4ef7\u4e0a\u6da8\uff0c\u6b64\u524d\u5236\u836f\u5de8\u5934<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=RHHBY\">\u7f57\u6c0f\u63a7\u80a1Roche Holding\uff08PINX:RHHBY\uff09<\/a>\u610f\u5916\u6cc4\u9732\u4e86\u6cbb\u7597PD-L1\u9ad8\u8868\u8fbe\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\uff08NSCLC\uff09\u7684\u4e09\u671f\u7814\u7a76SKYSCRAPER-01\u7684\u6570\u636e\u4e2d\u671f\u5206\u6790\u7ed3\u679c\u3002\u7f57\u6c0f\u968f\u540e\u5728\u5176\u5b98\u7f51\u6b63\u5f0f\u53d1\u5e03\u4e86\u8fd9\u4e00\u7ed3\u679c\u3002<\/p>\n<p>\u8be5\u7814\u7a76\u8bc4\u4f30\u7684\u662f\u5728\u7814TIGIT\u5355\u6297+PD-L1\u5355\u6297Tecentriq\uff08atezolizumab\uff09\u8054\u5408\u6cbb\u7597\u76f8\u6bd4Tecentriq\u5355\u836f\u6cbb\u7597\u7684\u6548\u679c\u3002\u867d\u7136\u603b\u751f\u5b58\u671f\uff08OS\uff09\u8fd9\u4e00\u8054\u5408\u4e3b\u8981\u7ec8\u70b9\u7684\u4e2d\u671f\u7ed3\u679c\u5c1a\u672a\u6210\u719f\uff0c\u4f46\u7ba1\u7406\u5c42\u62a5\u544a\u98ce\u9669\u6bd4\uff08HR\uff090.81\u3002\u7f57\u6c0f\u6253\u7b97\u5728\u5b8c\u6210\u6570\u636e\u7684\u6700\u7ec8\u5206\u6790\u4e4b\u540e\u7ee7\u7eed\u8be5\u7814\u7a76\u3002<\/p>\n<p>\u6309\u7167\u7f8e\u56fd\u56fd\u5bb6\u836f\u5b66\u56fe\u4e66\u9986\u5b98\u7f51\u7684\u89e3\u91ca\uff0c\u98ce\u9669\u6bd4\u76f8\u5f53\u4e8e\u5206\u7ec4\u5f53\u4e2d\u98ce\u9669\u66f4\u9ad8\u7684\u4e2a\u4f53\u9996\u5148\u8fbe\u5230\u7ec8\u70b9\u7684\u6982\u7387\u3002\u56e0\u6b64\uff0c\u8fd9\u4e00\u6bd4\u7387\u8d8a\u9ad8\u5f88\u6709\u53ef\u80fd\u8bf4\u660etiragolumab-Tecentriq\u8054\u5408\u6cbb\u7597\u76f8\u6bd4Tecentriq\u5355\u836f\u6cbb\u7597\u66f4\u52a0\u6709\u6548\u3002\u6570\u636e\u6cc4\u9732\u540e\uff0c\u7f57\u6c0f\u7684\u80a1\u4ef7\u5468\u4e09\u5927\u6da84.3%\u3002<\/p>\n<p>\u4e0d\u8fc7\uff0c\u6b64\u6b21\u6cc4\u9732\u4e8b\u4ef6\u63d0\u632f\u7684\u80a1\u7968\u4e0d\u6b62\u7f57\u6c0f\u4e00\u5bb6\uff0c\u5176\u4ed6\u6b63\u5728\u5f00\u53d1\u6297TIGIT\u514d\u75ab\u7597\u6cd5\u7684\u5c0f\u516c\u53f8\u7684\u80a1\u4ef7\u4e5f\u8ddf\u7740\u4e0a\u6da8\uff0c\u6bd4\u5982\u8bf4Arcus Biosciences Inc.\uff08NYSE:RCUS\uff09\u548cIteos Therapeutics Inc\uff08NASDAQ:ITOS\uff09\u7684\u80a1\u4ef7\u5206\u522b\u4e0a\u6da822.4%\u548c14.9%\u3002\u8ddf\u7f57\u6c0f\u4e00\u6837\uff0c\u8fd9\u4e9b\u516c\u53f8\u4e5f\u5728\u7814\u7a76\u5b83\u4eec\u7684TIGIT\u5019\u9009\u4ea7\u54c1\u8054\u5408\u6297PD-1\/L1\u7597\u6cd5\u6cbb\u7597\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u7684\u6548\u679c\u3002<\/p>\n<p>\u5177\u4f53\u6765\u770b\uff0cArcus Biosciences\u7684TIGIT\u6297\u4f53domvanalimab\u8054\u5408\u8be5\u516c\u53f8\u7684\u6297PD-1\u7597\u6cd5zimberelimab\u7684\u4e09\u671f\u7814\u7a76ARC-10\u4e5f\u5728\u8fdb\u884c\u4e2d\uff0cdomvanalimab+zimberelimab\u662f\u4f5c\u4e3a\u6cbb\u7597PD-L1\u9ad8\u8868\u8fbe\u5c40\u90e8\u665a\u671f\u6216\u8f6c\u79fb\u6027\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u7684\u4e00\u7ebf\u6cbb\u7597\u3002Arcus Biosciences\u8054\u5408\u5409\u5229\u5fb7\u79d1\u5b66Gilead Sciences\uff08NASDAQ:GILD\uff09\u5171\u540c\u5f00\u53d1\u8fd9\u4e24\u79cd\u836f\u7269\u3002<\/p>\n<p>iTeos Therapeutics\u4e3b\u8981\u7684\u5019\u9009\u5728\u7814\u836f\u7269\u662f\u6297TIGIT\u5355\u514b\u9686\u6297\u4f53belrestotug\uff0c\u8be5\u836f\u7269\u8054\u5408\u845b\u5170\u7d20\u53f2\u514bGSK\uff08NYSE:GSK\uff09\u7684\u6297PD-1\u836f\u7269Jemperli (dostarlimab)\u6cbb\u7597\u591a\u79cd\u514d\u75ab\u80bf\u7624\u9002\u5e94\u75c7\u7684\u591a\u4e2a\u8054\u5408\u7814\u7a76\u6b63\u5728\u8fdb\u884c\u4e2d\u3002\u8ddfSKYSCRAPER-01\u7814\u7a76\u7c7b\u4f3c\uff0ciTeos Therapeutics\u76ee\u524d\u6b63\u5728\u8fdb\u884cbelrestotug-Jemperli\u8054\u5408\u6cbb\u7597\u2014\u2014PD-1\u9ad8\u8868\u8fbe\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\u7684\u4e00\u7ebf\u6cbb\u7597\u2014\u2014\u540e\u671f\u7814\u7a76\u7684\u51c6\u5907\u5de5\u4f5c\u3002iTeos\u6b63\u8054\u5408\u845b\u5170\u7d20\u53f2\u514b\u5171\u540c\u5f00\u53d1belrestotug\u3002<\/p>\n<p>TIGIT\u662f\u4e00\u4e2a\u65b0\u7684\u6291\u5236\u6027\u514d\u75ab\u68c0\u67e5\u70b9\uff0c\u6291\u5236\u7684\u662f\u514d\u75ab\u7cfb\u7edf\u5bf9\u764c\u75c7\u7684\u53cd\u5e94\u3002\u5c3d\u7ba1TIGIT\u901a\u8def\u662f\u4e0d\u540c\u7684\uff0c\u4f46\u5b83\u4e0ePD-L1\/PD-1\u901a\u8def\u4e92\u8865\u3002\u7814\u7a76\u4eba\u5458\u76f8\u4fe1\uff0c\u6297TIGIT\u7597\u6cd5\u548cPD-1\/L1\u7597\u6cd5\u7684\u53cc\u91cd\u963b\u65ad\u6709\u53ef\u80fd\u6709\u52a9\u4e8e\u514b\u670d\u514d\u75ab\u6291\u5236\u5e76\u6062\u590d\u514d\u75ab\u53cd\u5e94\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>8\u670823\u65e5\uff0c\u4e00\u6279\u751f\u7269\u5236\u836f\u516c\u53f8\u7684\u80a1\u4ef7\u4e0a\u6da8\uff0c\u6b64\u524d\u5236\u836f\u5de8\u5934\u7f57\u6c0f\u63a7\u80a1Roche Holding\uff08PINX:RHHBY\uff09 [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":426793,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,747,925,1997],"class_list":["post-470530","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-747","tag-925","tag-1997","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/470530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=470530"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/470530\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/426793"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=470530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=470530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=470530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}